Rostock site

At the Rostock site, regenerative medicine is one of the university's key research activities in connection with biomedical technology which invigorates the Rostock University through the profile line "Life, Light and Material". Members of the SFB/Transregio 37 at the Rostock location are involved to a great extent there. With the third party projects acquired since the SFB/Transregio 37's start of funding, the acquired collaborative project "REMEDIS – Higher quality of living through new types of microimplants" (2009-2014) as part of the programme funded by BMBF "Top Level Research and Innovation in the New Federal States" is to be especially underscored. The goal of the collaborative project is the development of new types of implants for highly specific clinical applications and new possibilities for the therapy of disorders that have, up to now, not been adequately treatable.

REMEDIS brings together partners of SFB/Transregio 37 at the Rostock, Hannover and Aachen locations with well-known companies and other universities and research facilities. For the Rostock University, the bundling of research competencies of the three locations means a strengthening of the existing research concentration on regenerative medicine with a diversification into the competencies of material development and clinical research at the Aachen and Hannover sites. The methods available in Rostock in the area of biomaterial research, stem cell technology, nanotechnology, medication-loaded implant surfaces and the methods developed here in the in-vivo microscopy could together with the Hannover and Aachen locations already make major contributions to the reconstruction of biological functions.

A further major project acquired since the beginning of the SFB/Transregio 37 funding is the Reference and Translation Center for Cardiac Stem Cell Therapy (RTC) promoted by BMBF (2008-2016). The RTC is one of five centres for regenerative medicine in Germany and develops new regenerative therapies with adult stem cells for heart disease under GLP, GMP and GCP standards. In October 2009, the prospective, randomised and double-blind clinical study PERFECT on the injection of autologous stem cells from bone marrow during a bypass operation for the improvement of heart function began here. A similarity of content to the SFB/Transregio 37 also exists to the SFB 652 "Strong correlations and collective phenomena in radiation fields: Coulomb systems, Clusters and Particles" which is also located at the Rostock University. SFB 652 works in the area of physical basics of new laser technology with the potential for application in medicine.